As part of an ERC Consolidator grant (the 'MuSyC' project funded by the European Commission – Grant Agreement N° 101229996) aimed at developing new antibody-drug conjugates for cancer treatment, we are seeking a talented and motivated postdoctoral researcher (M/F) to join our team. The successful candidate will play a central role in project management, in liaising with partners, and in the design, production and characterisation of conjugates, which may lead to translational commercialisation activities in collaboration with the SATT Conectus (https://www.conectus.fr/). The successful candidate will be involved at every key stage of the development process, from the selection of conjugation strategies through to the analysis of finished products.
This role requires solid expertise in project management within synthetic chemistry and biomolecular chemistry. The ability to thrive in a multidisciplinary and collaborative environment will be essential, as will knowledge of therapeutic antibodies and targeted therapies, as well as chemical bioconjugation.
This role offers the opportunity to design and actively contribute to the development of research projects with high therapeutic potential within a dynamic team, with the ultimate aim of developing new therapeutic candidates for preclinical evaluation.
